Adiposity, mortality, and disease risk: insights from bioimpedance analysis and magnetic resonance imaging
New study by IARC in collaboration with Centre Léon Bérard and the University of Regensburg
Quantifying body fat and its association with cancer and mortality
A new study coordinated by IARC and international partners examined the relationship between measures of body fatness and risk of cancer and other diseases.
Using data from large-scale cohorts, researchers compared adiposity indices derived from bioimpedance analysis and magnetic resonance imaging (MRI) to assess accuracy and predictive value.
The findings confirm that excess adiposity significantly increases the risk of several obesity-related cancers, in addition to elevating all-cause mortality.
The study emphasizes that while BMI remains a common indicator, more precise measures of body composition can better capture the metabolic and oncogenic implications of fat distribution. The authors recommend that future prevention policies incorporate detailed adiposity metrics for improved cancer-risk prediction.
The results strengthen the scientific rationale for public-health strategies promoting weight control and lifestyle modification as cornerstones of cancer prevention.
Subscribe to our newsletter to get news and updates.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
This website is managed by 6th DYPEDE, Greece.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959